FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Roche Xofluza OK for Acute Uncomplicated Flu

[ Price : $8.95]

FDA approves a Roche a supplemental NDA for Xofluza (baloxavir marboxil) for treating acute uncomplicated influenza in certain chi...

4 Senators Urge Study on Pulse Oximeters

[ Price : $8.95]

Citing lingering questions about pulse oximeters, four Senate Democrats urge FDA to initiate a post market study of the devices.

Daiichi Sankyo Enhertu Approved for Lung Cancer

[ Price : $8.95]

FDA grants Daiichi Sankyo accelerated approval for Enhertu for treating adult patients with unresectable or metastatic non-small c...

Suit Questions FDA Patent Certification Authority

[ Price : $8.95]

Attorney Sara Koblitz says an Avadel suit against FDA challenges the agency's authority to list some patents in the Orange Book an...

MaaT013 Clinical Hold Still in Place

[ Price : $8.95]

FDA says its clinical hold on a MaaT Pharma Phase 3 trial of an investigational graft-versus-host disease drug remains in place wh...

Info Collection on Mammography Quality Standards

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension entitled "Mammography Quality Standards Act Req...

Info Collection on Environmental Impact Considerations

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection revision entitled: "Environmental Impact Considerations."

Medical Device Accessories Information Collection

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection extension entitled "Medical Device Accessories."

BD Intraosseous Devices Class 1 Recall

[ Price : $8.95]

FDA says the Becton Dickinson recall of three intraosseous medical devices is Class 1.

Menarini/Radius Submit Breast Cancer NDA

[ Price : $8.95]

The Menarini Group, supported by Radius Health, submits an NDA to FDA for elacestrant to treat some breast cancers.